Indeed, transcriptome data shows that cholesterol biosynthesis gene activation is associated with poor prognoses in melanoma patients [17], however, the expression of cholesterol biosynthesis limiting enzymes HMGCR was down-regulated in melanoma patients according to analysis of TCGA-SKCM and GSE3189 transcriptome data (Supplementary Figure 2). Here, HMGCR is linked to melanoma.